Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

Also called NCT02187757

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 180 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as a collaborator
Registry
  • NCT NCT02187757
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02187757. Randomized; quadruple masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2014-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels
Acronym
Prelip
Condition
Hyperlipidemia
Intervention (Dietary supplement)
Study Dietary Supplement (Prelipid 500 mg capsules)
Intervention (Dietary supplement)
Placebo
Lead sponsor
PreEmptive Meds, Pvt. Ltd (class: industry)
Collaborator
Abbott (class: industry)

Record details

Record id
cardio:ct-nct02187757
Content hash
46bc8f012c2db7179ad1ce8c614697cfe83f2d49477c9a487ac992a006dfee54